Page last updated: 2024-09-03

parecoxib and Sepsis

parecoxib has been researched along with Sepsis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, Q; Guo, Y; Min, S; Wu, B1
Clement, HW; Jargon, D; Schulz, K; Sommer, O; Strate, T; Utzolino, S; von Dobschuetz, E1
Bosselmann, S; Chada, M; Gessner, A; Kandler, M; Nögel, SC; Rascher, W; Schmidt, AM; Schneider, H; Schweer, H; Watzer, B1

Other Studies

3 other study(ies) available for parecoxib and Sepsis

ArticleYear
Parecoxib ameliorates renal toxicity and injury in sepsis-induced mouse model and LPS-induced HK-2 cells.
    Drug development research, 2022, Volume: 83, Issue:3

    Topics: Acute Kidney Injury; Animals; Apoptosis; Cyclooxygenase 2; Disease Models, Animal; I-kappa B Kinase; Inflammation; Isoxazoles; Lipopolysaccharides; Mice; NF-kappa B; Sepsis

2022
Cytokine and radical inhibition in septic intestinal barrier failure.
    The Journal of surgical research, 2015, Volume: 193, Issue:2

    Topics: Animals; Cyclic N-Oxides; Cyclooxygenase 2 Inhibitors; Drug Evaluation, Preclinical; Free Radical Scavengers; Interleukin-6; Intestinal Mucosa; Isoxazoles; Lipopolysaccharides; Male; Multiple Organ Failure; NADPH Oxidases; Neutrophils; Permeability; Pyruvic Acid; Rats, Sprague-Dawley; Sepsis; Spin Labels; Vasoactive Intestinal Peptide

2015
Parecoxib does not suppress thromboxane synthesis in newborn piglets with group B streptococcal sepsis.
    Prostaglandins & other lipid mediators, 2009, Volume: 90, Issue:1-2

    Topics: Animals; Animals, Newborn; Cyclooxygenase 2 Inhibitors; Dinoprostone; Epoprostenol; Gene Expression Regulation; Hemodynamics; Indomethacin; Inflammation; Isoxazoles; Lung; Platelet Count; Receptors, Prostaglandin E; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Swine; Thromboxanes

2009